For example, lenvatinib suppresses Src/STAT3/NF-κB signaling, inhibits HCC cell proliferation, reduces invasion ability, and induces apoptosis, thereby enhancing radiosensitivity [29]. This evidence concerns the gene NFKB1 and hepatocellular carcinoma.